Stock Events

Marksans Pharma . 

₹168.05
33
-₹0.95-0.56% Today

Statistics

Day High
172
Day Low
167.15
52W High
185.5
52W Low
70.55
Volume
1,688,335
Avg. Volume
1,883,266
Mkt Cap
78.01B
P/E Ratio
24.38
Dividend Yield
0.3%
Dividend
0.5

Upcoming

Dividends

0.3%Dividend Yield
10Y Growth
17.46%
5Y Growth
58.49%
3Y Growth
25.99%
1Y Growth
N/A

Earnings

28MayExpected
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Next
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MARKSANS.NSE. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Marksans Pharma Limited, together with its subsidiaries, engages in the research and development, manufacturing, marketing, and sale of generic pharmaceutical formulations worldwide. The company offers products in the analgesics, benign prostatic hyperplasia, antidiabetic, epilepsy, anti-inflammatory, hyperparathyroidism, diabetes, antacids, neurology, cardiovascular, hormonal, oncology, gastroenterology, antidiabetic, pain management, gynecology, antifungal, antiulceratives, vitamins, dermatology, cephalosporins, injectables, anti-allergy, antibacterial, and hypertension therapeutic areas. Marksans Pharma Limited was incorporated in 1992 and is headquartered in Mumbai, India.
Show more...
CEO
Mr. Mark B. Saldanha
Employees
852
Country
IN
ISIN
INE750C01026

Listings